Skip to content

Advertisement

Open Peer Review Reports for: The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
1 Mar 2017 Submitted Original manuscript
23 May 2017 Author responded Author comments - Ibrahim Babikir
Resubmission - Version 2
23 May 2017 Submitted Manuscript version 2
26 Jul 2017 Reviewed Reviewer Report - David Hains
2 Aug 2017 Author responded Author comments - Ibrahim Babikir
Resubmission - Version 3
2 Aug 2017 Submitted Manuscript version 3
22 Sep 2017 Reviewed Reviewer Report - David Hains
8 Nov 2017 Author responded Author comments - Ibrahim Babikir
Resubmission - Version 4
8 Nov 2017 Submitted Manuscript version 4
3 Dec 2017 Author responded Author comments - Ibrahim Babikir
Resubmission - Version 5
3 Dec 2017 Submitted Manuscript version 5
Publishing
10 Dec 2017 Editorially accepted
8 Jan 2018 Article published 10.1186/s12879-017-2901-z

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement